US 11253522
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted A61KA61K31/519A61K45/06
Quick answer
US patent 11253522 (Cancer treatment targeted to tumor adaptive responses to protein synthesis stress) held by The Regents of the University of California expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/519, A61K45/06, A61P, A61P35/02